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We investigated mechanisms for the neuritogenesis caused by prostaglandin E2 (PGE2) or intracellular
cyclic AMP (cAMP) in sensory neuron-like ND7/23 cells. PGE2 caused neuritogenesis, an effect abolished
by an EP4 receptor antagonist or inhibitors of adenylyl cyclase (AC) or protein kinase A (PKA) and
mimicked by the AC activator forskolin, dibutyryl cAMP (db-cAMP), and selective activators of PKA or
Epac. ND7/23 cells expressed both Cav3.1 and Cav3.2 T-type Ca2þ channels (T-channels). The neurito-
genesis induced by db-cAMP or PGE2 was abolished by T-channel blockers. T-channels were functionally
upregulated by db-cAMP. The PGE2/EP4/cAMP/T-channel pathway thus appears to mediate neurito-
genesis in sensory neurons.
© 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Injury to the peripheral axons of the primary sensory neurons
triggers a variety of cell signals in the neurons and related cells,
which stimulates axonal regeneration and may eventually
contribute to the later development of neuropathic pain (1). One of
the most important intracellular molecules for the axonal regen-
eration is cyclic AMP (cAMP) in the neuronal cytoplasm, since
dibutyryl cAMP (db-cAMP), a membrane-permeable cAMP
analogue capable of inhibiting phosphodiesterase (PDE), a cAMP-
degrading enzyme, enhances neurite outgrowth in cultured dor-
sal root ganglion (DRG) neurons (2). There is also in vivo evidence
that microinjection of db-cAMP into the DRG promotes the
regrowth of injured axons (3), although the surrounding cells such
as Schwann cells and macrophages also participate in the regen-
erative process (1,4). On the other hand, prostaglandin E2 (PGE2)
causes cAMP-dependent neuritogenesis in cultured DRG neurons
(2). We have shown that PGE2 enhances protein kinase A (PKA)-
dependent enhancement of T-type Ca2þ channel (T-channel) ac-
tivity via EP4 receptors, contributing to the development of me-
chanical hyperalgesia (5), and that the enhanced activity of T-ology and Pathophysiology,
ae, Higashi-Osaka 577-8502,
wabata).
rmacological Society.
. Production and hosting by Elsechannels by hydrogen sulﬁde, a gasotransmitter, causes neurito-
genesis in the neuron-like NG108-15 cells (6,7). To clarify the cell
signals underlying the axonal regeneration in injured primary af-
ferents, in the present study, we analyzed possible involvement of
PGE2, cAMP and T-channels in the neuritogenesis in ND7/23 cells,
created by cell fusion of N18Tg2 mouse neuroblastoma and DRG
neurons from neonatal rats, which express substance P and have
nociceptive sensory neuron-like properties (8,9).
ND7/23 cells were cultured in a low glucose-containing Dul-
becco's modiﬁed Eagle's medium (Wako Pure Chemical Industries,
Osaka, Japan) supplemented with 100 U/mL penicillin, 100 mg/mL
streptomycin (Gibco, Carlsbad, CA, USA) and 10% fetal bovine serum
(FBS) (Thermo Electron Corporation, Waltham, MA, USA). The cells
were seeded at a density of 1  104/mL in a culture dish (35 mm in
diameter) coated with poly-L-ornithine and ﬁlled with 1 mL of the
above medium containing 1% FBS, and stimulated with distinct
chemicals including PGE2 and db-cAMP for 24, 48, 72 or 96 h at
37 C. Neurite outgrowth was evaluated by counting cells with
neurites that were longer than the cell body diameter (two ﬁelds
from each dish) under the microscope, as described elsewhere
(6,7). T-channel-dependent membrane currents (T-currents) were
determined by whole-cell patch-clamp recordings in ND7/23 cells
stimulated with db-cAMP, as reported previously (5e7). Brieﬂy,
Ba2þ currents were recorded from randomly chosen cells at room
temperature (22e24 C) using a computer-controlledvier B.V. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. PGE2 causes neurite outgrowth via the EP4/adenylyl cyclase/PKA pathway in
ND7/23 cells. (A) Typical photographs of neuritogenesis in ND7/23 cells stimulated
with PGE2 at 10 mM plus IBMX, a PDE inhibitor, at 50 mM or the vehicle (V) for 24 h.
Arrows indicate neurites. (B, C) Neurite outgrowth after 24-h stimulation with IBMX
(B) or PGE2 plus IBMX (C). (DeF) Effects of SC19220, AH6809 and SH23848, EP1, EP2
and EP4 antagonists, respectively, at 10 mM on the neurite outgrowth caused by 24-h
stimulation with PGE2 at 10 mM plus IBMX at 50 mM. (G) Neurite outgrowth after 24-h
stimulation with sulprostone, an EP3/EP1 agonist, or PGE2 in the presence of 50 mM
IBMX. (H, I) Effects of SQ22536, an adenylyl cyclase inhibitor, at 500 mM and KT5720, a
PKA inhibitor, at 1e10 mM on the PGE2/IBMX-induced neuritogenesis. Each inhibitor or
antagonist was applied to the cells 30 min before the stimulation (DeF, H, I). Data show
the mean with SEM for 4e8 (B, C), 8e12 (EeF) or 8 (GeI) different experiments. n.s.,
not signiﬁcant.
K. Mitani et al. / Journal of Pharmacological Sciences 130 (2016) 177e180178microelectrode ampliﬁer (MultiClamp 700B, Axon Instruments,
Foster City, CA, USA). The resistance of patch pipettes ranged from 3
to 5 MU, and series-resistance was compensated by 80%. Data were
acquired and digitized with a Digidata interface (1322A, Axon In-
struments), and analyzed by a personal computer using pClamp8
software (Axon Instruments). Current-voltage relations were
analyzed by applying 200-ms test-pulse potentials ranging in 10-
mV steps from 120 to þ30 mV, from a holding potential
of 90 mV. T-currents were evaluated by depolarizing the cells
to20mV from the same holding potential. Protein expressionwas
analyzed by Western blotting, essentially as reported previously
(5). The primary antibodies used (dilution) were: a goat anti-Epac1
(C-17) antibody (1:200), goat anti-Epac2 (M-18) antibody (1:200),
rabbit anti-GAPDH antibody (1:3000) (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA), rabbit anti-Cav3.1 antibody (1:500)
(Alomone Labs, Jerusalem, Israel), and rabbit anti-Cav3.2 antibody
(1:500) (Sigma-Genosis/SigmaeAldrich, St. Louis, MO, USA). The
secondary antibodies used (dilution) were: a horseradish peroxi-
dase (HRP)-conjugated anti-rabbit IgG antibody (1:2000) (Chem-
icon International Inc., Billerica, MA, USA) or anti-goat IgG antibody
(1:3000) (Millipore Corporation, Billerica, MA, USA). Expression of
mRNA for Epac1 and Epac2 was conﬁrmed by the conventional RT-
PCR method, as described elsewhere (10). The PCR primers used
were: 50-GCT CTC CCC TCC TGT CAT CC-30 (forward) and 50-GTT CCC
GCT GGT TGT CAA TG-30 (reverse) for Epac1 (PCR product size:
323 bp); 50-CCT TCC TGG AGG AGT TCT AT-30 (forward) and 50-GTG
ACA ACC CAA AAC TGA AT-30 (reverse) for Epac2 (PCR product size:
688 bp). According to the procedures approved by the Committee
for the Care and Use of Laboratory Animals at Kindai University, the
cerebellum and DRG were excised from male Wistar rats (9e12
weeks old) (Japan SLC Inc., Shizuoka, Japan) that had been sacri-
ﬁced by exsanguination under anesthesia with i.p. urethane at
1.5 g/kg. The homogenates were used as positive controls that ex-
press mRNA and/or protein of Epac1 or Epac2. PGE2, db-cAMP, 3-
isobutyl-1-methylxanthine (IBMX), forskolin, KT5720, SC19220,
NNC55-0396 (NNC), mibefradil, AH6809, sulprostone, SH23848,
SQ22536, N6-benzoyl-cAMP (6-Bnz-cAMP) and ascorbic acid were
purchased from SigmaeAldrich (St. Louis, MO, USA). ZnCl2 was
obtained from Kishida Chemical (Osaka, Japan), and 8-(4-
chlorophoenylthio)-20-O-methyl-cAMP (8-CPT-20-O-Me-cAMP)
was from BIOLOG Life Science Institute (Bremen, Germany). Data
are shown as themean± SEM. Statistical analysis was performed by
Student's t-test for two group data and Tukey's test for multiple
comparisons. Signiﬁcance was set at a p < 0.05 level.
In ND7/23 cells, stimulation with PGE2 at 2e10 mM for 24 h
caused signiﬁcant neurite outgrowth in the presence of IBMX, a
PDE inhibitor, at 50 mM, a subeffective concentration (Fig. 1AeC).
The neurite outgrowth caused by PGE2 at 10 mMplus IBMX at 50 mM
was signiﬁcantly inhibited by SH23848, an EP4 receptor antagonist,
at 10 mM, but not SC19220, an EP1 receptor antagonist, or AH6809,
an EP2 receptor antagonist, at 10 mM (Fig. 1DeF). Sulprostone, an
EP3/EP1 agonist, in a range of 1e100 mM failed to mimic the PGE2-
induced neuritogenesis in the presence of IBMX (Fig. 1G). The PGE2/
IBMX-induced neurite outgrowth was also signiﬁcantly suppressed
by SQ22536 at 500 mM and KT5720 at 1e10 mM, inhibitors of ade-
nylyl cyclase and PKA, respectively, known as downstream signals
of the trimeric Gs protein-coupled receptor EP4 (Fig. 1H, I).
Collectively, PGE2 is considered to cause neuritogenesis via acti-
vation of EP4 receptors, adenylyl cyclase and PKA in ND7/23 cells.
Stimulation with db-cAMP, a membrane-permeable cAMP
analogue capable of inhibiting PDE, at 1 mM for 24, 48 or 72 h
produced neurite outgrowth (Fig. 2A, B), an effect reduced by the
PKA inhibitor KT5720 (Fig. 2E). Like PGE2, forskolin, an adenylyl
cyclase activator, at 3 mM also elicited neuritogenesis in the pres-
ence, but not absence, of IBMX (Fig. 2C, D). 6-Bnz-cAMP, a selectivePKA activator, at 500 mM caused KT5720-sensitive neurite
outgrowth (Fig. 2F, G). 8-CPT-20-O-Me-cAMP, a selective activator of
Epac, another target for cAMP, at 100 mM mimicked the db-cAMP-
induced neuritogenesis (Fig. 2H). Combined application of 6-Bnz-
cAMP and 8-CPT-20-O-Me-cAMP at 100 and 20e50 mM, respec-
tively, subeffective concentrations, synergistically produced neurite
outgrowth (Fig. 2I). Proteins and mRNA for Epac1 and Epac2 were
detected in ND7/23 cells (Fig. 2J, K).
Fig. 2. Characterization of cAMP-dependent neurite outgrowth in ND7/23 cells. (A) Typical photographs of neuritogenesis in ND7/23 cells stimulated with 1 mM db-cAMP or
vehicle (V) for 24 h. (BeD) Neurite outgrowth after stimulation with db-cAMP for 24, 48 and 72 h (B) or forskolin, an adenylyl cyclase activator, in the absence (C) or presence (D) of
IBMX for 24 h. (E) Effect of the PKA inhibitor KT5720 on the neuritogenesis following 24-h stimulation with 1 mM db-cAMP. (F, G) Neurite outgrowth after 24-h stimulation with 6-
Bnz-cAMP (Bnz), a selective PKA activator, in the absence (F) or presence (G) of KT5720. (H, I) Neurite outgrowth after 24-h stimulation with 8-CPT-20-O-Me-cAMP (CPT), a selective
Epac activator, alone (H) or in combination with 6-Bnz-cAMP (I). Each inhibitor was applied to the cells 30 min before the stimulation (E, G). Data show the mean with SEM for 4e8
different experiments. n.s., not signiﬁcant (BeI). (J, K) Expression of protein (J) and mRNA (K) for Epac1 and Epac2 in ND7/23 cells and in rat DRG and/or cerebellum as the positive
control.
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major isoforms of T-channels (Fig. 3A). The neuritogenesis caused
by db-cAMP or PGE2 plus IBMX was abolished by NNC or mibe-
fradil, T-channel blockers, whereas it was resistant to ZnCl2 or
ascorbic acid, known to inhibit Cav3.2, but not Cav3.1 (11)Fig. 3. Involvement of T-channels in the neuritogenesis induced by db-cAMP or PGE2 þ IBM
Effects of T-channel blockers, NNC55-0396 (NNC) and mibefradil (Mibe), and of ZnCl2 and
outgrowth induced by 1 mM db-cAMP or by 10 mM PGE2 in combination with IBMX at 50 mM
30 min before the stimulation. (FeH) Effect of db-cAMP on Ba2þ currents in ND7/23 cells. Ba
The currentevoltage relationship of Ba2þ currents. Step pulses of 200-ms duration from 
potential of 90 mV. (G, H) T-currents were determined as the difference between the peak
from the holding potential of 90 mV. Data show the mean with SEM for 10e16 (B, C), 8e(Fig. 3BeE), suggesting possible involvement of Cav3.1, but not
Cav3.2, in the neuritogenesis evoked by PGE2 and cAMP. Stimula-
tionwith 1 mM db-cAMP for 4 days greatly enhanced Ba2þ currents
in ND7/23 cells (Fig. 3F). The T-currents, determined as the differ-
ence between the peak current and the current 150 ms after theX in ND7/23 cells. (A) Protein expression of Cav3.1 and Cav3.2 in ND7/23 cells. (BeE)
ascorbic acid (Asc), known to inhibit Cav3.2, but not Cav3.1 or Cav3.3, on the neurite
. NNC at 1 mM, Mibe at 1 or 3 mM, ZnCl2 at 10 mM or Asc at 1 mMwas applied to the cells
2þ currents were determined in the cells stimulated with 1 mM db-cAMP for 4 days. (F)
120 to þ30 mV with increments of 10 mV were applied to the cells, from a holding
current and the current 150 ms after the beginning of a 200-ms test pulse at 20 mV
12 (D, E), 26e29 (F) or 23e29 (H) different experiments. n.s., not signiﬁcant.
K. Mitani et al. / Journal of Pharmacological Sciences 130 (2016) 177e180180beginning of the 200-ms test pulse at 20 mV from a holding po-
tential of90mV (Fig. 3G), signiﬁcantly increased after stimulation
with db-cAMP (Fig. 3H).
We have shown that PGE2 enhances the EP4/cAMP/PKA-
dependent phosphorylation and channel activity of Cav3.2 in
NG108-15 cells (5). The present data provide evidence that the
PGE2/EP4/cAMP pathway participates in the neuritogenesis by
enhancing the activity of T-channels, most probably Cav3.1, in
nociceptive sensory neuron-like ND7/23 cells, which is consistent
with the report that Cav3.1 as well as Cav3.2 can be phosphorylated
and functionally upregulated by PKA (11,12). Like Cav3.2, Cav3.1 is
also expressed in DRG neurons and involved in nociceptive pro-
cessing, particularly in neuropathic pain (13,14), whereas the
localization of Cav3.1 in distinct subpopulations of DRG neurons has
yet to be clariﬁed. Our ongoing study thus focuses on the roles of
Cav3.1 and Cav3.2 in neuritogenesis in isolated DRG neurons. Our
results also suggest the involvement of Epac, in addition to PKA, in
the cAMP-dependent neuritogenesis in ND7/23 cells, in agreement
with the evidence that Epac is involved in cAMP-dependent axon
growth (15). Considering that the PKA inhibitor almost completely
suppressed the neuritogenesis induced by PGE2 plus IBMX or db-
cAMP (see Figs. 1I and 2E), the PKA pathway may play a critical
role, and the physiological relevance of the Epac pathway to cAMP-
dependent neuritogenesis is still open to question. The ﬁndings
that PGE2 or forskolin in the absence of IMBX did not cause neu-
ritogenesis indicate the strong and continuous degradation of
cAMP by PDE in ND7/23 cells, and suggest that persistent PGE2
generation followed by long-term cAMP production is required for
neuritogenesis. Together, we thus propose that the PGE2/EP4/
cAMP/T-channel pathway accelerates the axonal regeneration in
injured nociceptive sensory neurons, and that pharmacological
manipulation of this signaling pathway may be useful to shorten
the recovery time or prevent the delayed development of neuro-
pathic pain after neuronal injury.Conﬂicts of interest
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